![]() |
市场调查报告书
商品编码
1725121
2032 年血糖值试纸包装市场预测:按类型、材料、薄膜类型、技术、分销管道和地区进行的全球分析Blood Glucose Test Strip Packaging Market Forecasts to 2032 - Global Analysis By Type, Material Type, Film Type, Technology, Distribution Channel and By Geography |
根据 Stratistics MRC 的数据,全球血糖值试纸包装市场预计在 2025 年将达到 24 亿美元,到 2032 年将达到 44 亿美元,预测期内的复合年增长率为 8.6%。
血糖值试纸包装是指为保持用于监测血糖值的试纸的完整性和功能性而设计的专门外壳。这些包装可保护试纸免受潮湿、污染和外部损坏,确保读数准确。包装通常由耐用、防潮的材料製成,方便使用者取用,同时保持无菌。先进的设计融合了可重新密封的封盖、独立隔间和防篡改密封等特点,易于使用并提高安全性。
根据联合国儿童基金会的第一个目标产品概况,在资源匮乏的环境中,获得诊断实验室的帮助仍然是关键挑战。即时诊断测试使医疗保健专业人员能够提供更快、更有效的护理。
增加在家检测和远端患者监护
随着全球糖尿病盛行率的增加,方便、易得的血糖管理解决方案正成为优先事项。在家进行测试可以让患者监测血糖浓度,而无需频繁去诊所,从而降低医疗成本并改善疾病管理。此外,数位健康技术的进步使得试纸包装和智慧监控设备能够无缝集成,从而改善用户体验。
复杂的製造和供应链要求
製造商必须遵守监管标准,以确保包装材料不会损害测试条的完整性。此外,采购防潮膜和防篡改密封等特殊材料会增加生产成本。供应链中断,例如原材料短缺和运输困难,可能会影响及时分销,从而影响市场成长。
更加关注生物分解性或可回收材料
随着人们对环境问题的日益关注,医疗保健产业正在转向永续包装解决方案以减少塑胶废弃物。製造商正在探索环保替代品,例如生物分解性的薄膜和可回收的包装,以实现全球永续性目标。监管机构也鼓励采用环保包装方法,鼓励企业投资创新材料。此外,消费者对环境影响的认知正在影响购买决策,推动对永续医疗保健产品的需求。
更换为持续血糖监测(CGM)设备
CGM 技术提供即时血糖跟踪,无需频繁进行指尖采血测试,减少了对传统试纸的依赖。随着 CGM 的应用不断增加,尤其是那些需要高阶糖尿病管理的人,对血糖值试纸的需求可能会下降。此外,医疗保健提供者青睐 CGM 设备,因为它们能够提供全面的血糖趋势分析,从而改善治疗效果。
COVID-19 疫情以多种方式影响了血糖值试纸包装市场,既影响了供应链,也影响了消费行为。虽然最初製造和物流中断导致了暂时的供不应求,但这场危机也提高了人们对糖尿病管理的认识。患者优先考虑在家中进行检测以尽量减少去医院的次数,这推动了对试纸和可靠包装解决方案的需求。随着个人寻求便捷的监测工具,向远端医疗和远距医疗咨询的转变进一步推动了市场的成长。
预计预测期内管瓶/管部分将达到最大程度的成长。
由于试纸在储存中的广泛应用,预计管瓶/试管部分将在预测期内占据最大的市场占有率。管瓶和试管可提供卓越的防潮、防污染和防物理损坏保护,确保血糖值测量的准确性。其可重新密封的设计增加了便利性,使用户能够在保持无菌的同时使用测试条。
预计预测期内铝业将以最高的复合年增长率成长。
在预测期内,铝业预计将凭藉其优异的阻隔性能和永续性优势实现最高的成长率。铝包装具有防潮功能,有助于测试纸在各种环境条件下保存更长时间。此外,它的可回收性符合人们对环保医疗保健解决方案日益增长的关注,使其成为製造商的一个有吸引力的选择。该领域受益于轻质铝包装技术的进步,提高了便携性和用户便利性。
在预测期内,预计北美将占据最大的市场占有率,这得益于糖尿病的高盛行率和强大的医疗保健基础设施。该地区拥有成熟的医疗设备产业,领先的製造商正在投资先进的封装技术。此外,消费者对糖尿病管理和预防性医疗保健的认识正在推动对可靠的试纸包装解决方案的需求。
由于医疗保健投资增加、糖尿病患者数量增加以及医疗设备使用范围扩大,预计亚太地区将在预测期内实现最高的复合年增长率。中国、印度和日本等国家对血糖值监测工具的需求激增,推动了包装创新。政府推动提高糖尿病意识和早期诊断的倡议进一步推动了市场扩张。
According to Stratistics MRC, the Global Blood Glucose Test Strip Packaging Market is accounted for $2.4 billion in 2025 and is expected to reach $4.4 billion by 2032 growing at a CAGR of 8.6% during the forecast period. Blood glucose test strip packaging refers to specialized containment designed to preserve the integrity and functionality of test strips used for monitoring blood sugar levels. These packages protect the strips from moisture, contamination, and external damage, ensuring accurate readings. Typically made from durable, moisture-resistant materials, the packaging maintains sterility while allowing easy access for users. Advanced designs incorporate features like resealable closures, individual compartments, and tamper-evident seals to enhance usability and safety.
According to the UNICEF target product profile, 1st edition, access to diagnostic laboratories remains a key challenge in low-resource settings. Point-of-care diagnostic tests enable healthcare workers to provide more rapid and effective care.
Increased home-based testing and remote patient monitoring
As diabetes prevalence rises globally, individuals are prioritizing convenient and accessible solutions for blood glucose management. Home-based testing allows patients to monitor their glucose levels without frequent hospital visits, reducing healthcare costs and improving disease management. Additionally, advancements in digital health technologies are enabling seamless integration of test strip packaging with smart monitoring devices, enhancing user experience.
Complex manufacturing and supply chain requirements
Manufacturers must adhere to regulatory standards, ensuring that packaging materials do not compromise the integrity of test strips. Additionally, sourcing specialized materials such as moisture-resistant films and tamper-evident seals adds to production costs. Supply chain disruptions, including raw material shortages and transportation challenges, can impact timely distribution, affecting market growth.
Growing focus on biodegradable or recyclable materials
As environmental concerns rise, healthcare industries are shifting toward sustainable packaging solutions to reduce plastic waste. Manufacturers are exploring eco-friendly alternatives such as biodegradable films and recyclable containers to align with global sustainability goals. Regulatory bodies are also encouraging the adoption of green packaging practices, prompting companies to invest in innovative materials. Additionally, consumer awareness regarding environmental impact is influencing purchasing decisions, driving demand for sustainable healthcare products.
Substitution by continuous glucose monitoring (CGM) devices
CGM technology offers real-time glucose tracking without the need for frequent finger-prick tests, reducing reliance on traditional test strips. As CGM adoption increases, particularly among individuals with advanced diabetes management needs, demand for blood glucose test strips may decline. Additionally, healthcare providers are advocating for CGM devices due to their ability to provide comprehensive glucose trend analysis, improving treatment outcomes.
The COVID-19 pandemic had a mixed impact on the blood glucose test strip packaging market, influencing both supply chains and consumer behavior. While initial disruptions in manufacturing and logistics led to temporary shortages, the crisis also heightened awareness of diabetes management. Patients prioritized home-based testing to minimize hospital visits, increasing demand for test strips and reliable packaging solutions. The shift toward telemedicine and remote healthcare consultations further supported market growth, as individuals sought convenient monitoring tools.
The vials/tubes segment is expected to be the largest during the forecast period
The vials/tubes segment is expected to account for the largest market share during the forecast period due to its widespread use in test strip storage. Vials and tubes provide superior protection against moisture, contamination, and physical damage, ensuring the accuracy of blood glucose readings. Their resealable design enhances convenience, allowing users to access test strips while maintaining sterility.
The aluminum segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the aluminum segment is predicted to witness the highest growth rate driven by its superior barrier properties and sustainability advantages. Aluminum packaging offers excellent moisture resistance, ensuring the longevity of test strips in various environmental conditions. Additionally, its recyclability aligns with the growing focus on eco-friendly healthcare solutions, making it an attractive option for manufacturers. The segment is benefiting from technological advancements in lightweight aluminum packaging, enhancing portability and user convenience.
During the forecast period, the North America region is expected to hold the largest market share driven by high diabetes prevalence and strong healthcare infrastructure. The region has a well-established medical device industry, with leading manufacturers investing in advanced packaging technologies. Additionally, consumer awareness regarding diabetes management and preventive healthcare is fueling demand for reliable test strip packaging solutions.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising healthcare investments, increasing diabetes cases, and expanding access to medical devices. Countries such as China, India, and Japan are experiencing a surge in demand for blood glucose monitoring tools, driving packaging innovations. Government initiatives promoting diabetes awareness and early diagnosis are further supporting market expansion.
Key players in the market
Some of the key players in Blood Glucose Test Strip Packaging Market include Abbott, ACON Laboratories Inc., AgaMatrix, Amcor, Aptar CSP Technologies, ARKRAY Inc., Ascensia Diabetes Care, Bionime Corporation, LifeScan IP Holdings LLC, Multisorb, Procurenet Limited, Roche, Rossmax International Ltd, Sanner, Shijiazhuang Xinfuda Medical Packaging Co., Ltd., Trividia Health Inc., Wisesorbent Technology, and YuHuan KangJia.
In November 2024, Ascensia Diabetes Care, in collaboration with Fitterfly Healthtech, launched a 21-day Diabetes Management Program on World Diabetes Day. This initiative offers Ascensia glucometer users personalized support, including diet plans, AI wellness coaching, and expert guidance to simplify diabetes management.
In September 2024, Aptar CSP's N-Sorb Nitrosamine Mitigation Solution was accepted into the US FDA's Emerging Technology Program, addressing concerns related to N-nitrosamine impurities in pharmaceuticals.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.